日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory Properties

开发具有免疫刺激特性的靶向STEAP1的前列腺癌特异性抗体药物偶联物平台

Wang, John Shuhan; Sodhi, Sirajbir S; Tsao, Li-Chung; Lin, Guang Han; Moon, Nicole; Zhang, Qiang; Liu, Bushangqing; Penaranda, Juliet; Trotter, Timothy N; Somarelli, Jason A; Armstrong, Andrew J; Lyerly, H Kim; Wang, Guangdi; Hartman, Zachary C

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)

有效的细胞外有效载荷释放和免疫调节相互作用决定了曲妥珠单抗德鲁替康(T-DXd)的治疗效果。

Li-Chung Tsao ,John S Wang ,Xingru Ma ,Sirajbir Sodhi ,Joey V Ragusa ,Bushangqing Liu ,Jason McBane ,Tao Wang ,Junping Wei ,Cong-Xiao Liu ,Xiao Yang ,Gangjun Lei ,Ivan Spasojevic ,Ping Fan ,Timothy N Trotter ,Michael Morse ,Herbert Kim Lyerly ,Zachary C Hartman